Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: Normalization by treatment with a proton pump inhibitor

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 2, 2008, Pages 303-309

  Mine, Shinichiro ^a   Iida, Takeshi ^c   Tabata, Takahiro ^b   Okada, Yosuke ^b   Tanaka, Yoshiya ^b  

^a Hagiwara Central Hospital   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c YAMAGUCHI ROSAI HOSPITAL   (Japan)

Author keywords

Esophageal mucosal blood flow; Gastroesophageal reflux disease; Proton pump inhibitors

Indexed keywords

FAMOTIDINE; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HISTOLOGY; HUMAN; HUMAN TISSUE; LASER DOPPLER FLOWMETRY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBMUCOSA; THERAPY EFFECT; THICKNESS;

EID: 39149085316     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05113.x     Document Type: Article

References (35)

1. Pique JM, Leung FW, Tan HW et al. Gastric mucosal blood flow response to stimulation and inhibition of gastric acid secretion. Gastroenterology 1988 95 : 642 50.
2. Hollwarth ME, Smith M, Kvietys PR et al. Esophageal blood flow in the cat. Gastroenterology 1986 90 : 622 7.
3. Feldman MJ, Morris GP, Dinda PK et al. Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology 1996 110 : 121 8.
4. Mine S, Fujisaki T, Tabata T et al. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux. Am. J. Gastroenterol. 2000 95 : 381 6.
5. Mine S, Iida T, Tabata T et al. Management of symptoms in step-down therapy of gastro-esophageal reflux disease. J. Gastroenterol. Hepatol. 2005 20 : 1365 70.
6. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol. 1998 33 : 1023 9.
7. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagus: a progress report on observer agreement. Gastroenterology 1996 111 : 85 92.
8. Takamatsu A, Inoue T, Kurihara T et al. Predicting impaired perfusion in flap monitoring with laser doppler flowmeter. J. Jpn. P. R. S. 2000 20 : 81 9.
9. Johansson K, Ahn H, Lindhagen J et al. Tissue penetration and measuring depth of laser doppler flowmeter in the gastrointestinal application. Scand. J. Gastroenterol. 1987 22 : 1081 8.
10. Johansson K. Gastrointestinal application of laser doppler flowmetry. An experimental and clinical study in cat and human. Acta Chir. Scand. Suppl. 1988 545 : 1 64.
11. Igawa M, Miyaoka M, Saitoh T. Influence of topical epinephrine application on microcirculatory disturbance in subjects with ulcerative colitis evaluated by laser doppler flowmetry and transmission electron microscopy. Dig. Endosc. 2000 12 : 126 30.
12. Sandler AD, Schmidt C, Richardson K et al. Regulation of distal esophageal mucosal blood flow: the role of nitric oxide and substance P. Surgery 1993 114 : 285 94.
13. Bass BL, Schweitzer EJ, Harmon JW et al. H+ back diffusion interferes with intrinsic reactive regulation of esophageal mucosal blood flow. Surgery 1984 96 : 404 13.
14. Bass BL, Trad KS, Harmon JW et al. Capsaicin-sensitive nerves mediate esophageal mucosal protection. Surgery 1991 110 : 419 26.
15. McKie LD, Dunkin BJ, Pennanen MF et al. Esophageal mucosal blood flow: a central role for calcitonin gene-related peptide. Surgery 1994 116 : 409 18.
16. McKie LD, Bass BL, Dunkin BJ et al. Nitric oxide regulates basal but not capsaicin-, CGRP-, or bile salt-stimulated rabbit esophageal mucosal blood flow. Ann. Surg. 1995 222 : 186 92.
17. Caviglia R, Ribolsi M, Maggiano N et al. Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am. J. Gastroenterol. 2005 100 : 543 8.
18. Martinez SD, Malagon IB, Garewal HS et al. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment. Pharmacol. Ther. 2003 17 : 537 45.
19. Kawamura O, Sekiguchi T, Kusano M et al. Endoscopic ultrasonographic abnormalities and lower esophageal sphincter function in reflux esophagitis. Dig. Dis. Sci. 1995 40 : 598 605.
20. Funch-Jensen P, Kock K, Christensen A et al. Microscopic appearance of the esophageal mucosa in a consecutive series of patients, submitted to upper endoscopy. Scand. J. Gastroenterol. 1986 21 : 65 9.
21. Kiesslich R, Kanzler S, Vieth M et al. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig. Dis. 2004 22 : 221 7.
22. Caletti GC, Ferrari A, Mattioli S et al. Endoscopy versus endoscopic ultrasonography in staging reflux esophagitis. Endoscopy 1994 26 : 794 7.
23. Adrain AL, Ter HC, Cassidy ML et al. High-resolution endoluminal sonography is a sensitive modality for the identification of Barrett's metaplasia. Gastrointest. Endosc. 1997 46 : 147 51.
24. Miller L, Dai Q, Korimilli A et al. Use of endoluminal ultrasound to evaluate gastrointestinal motility. Dig. Dis. 2006 24 : 319 41.
25. Fox VL, Nurko S, Teitelbaun JE et al. High-resolution EUS in children with 'eosinophilic allergic' esophagitis. Gastrointest. Endosc. 2003 57 : 30 6.
26. Delaney JP, Custer J. Gastrointestinal blood flow in the dog. Circ. Res. 1965 17 : 394 402.
27. Fujiwara H, Kuga T, Esato K. High submucosal blood flow and low anastomotic tension prevent anastomotic leakage in rabbits. Jpn. J. Surg. 1997 27 : 924 9.
28. Wandall JH. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation and translocation of cytochrome b-245. Gut 1992 33 : 617 21.
29. Yoshida N, Uchiyama K, Kuroda M et al. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand. J. Gastroenterol. 2004 39 : 816 22.
30. Yoshida N, Yoshikawa T, Tanaka Y et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment. Pharmacol. Ther. 2000 14 (Suppl. 1 74 81.
31. Suzuki M, Nakamura M, Mori M et al. Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J. Chin. Gastroenterol. 1995 20 (Suppl. 2 s93 6.
32. Ohara T, Arakawa T. Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig. Dis. Sci. 1999 44 : 1710 15.
33. Stolte M, Vieth M, Schmitz JM et al. Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus. Scand. J. Gastroenterol. 2000 35 : 1125 30.
34. Castell DO, Richter JE, Robinson M et al. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. Am. J. Gastroenterol. 1996 91 : 1749 57.
35. Richter JE, Kahrilas PJ, Sontag SJ et al. Comparison lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients. Am. J. Gastroenterol. 2001 96 : 3089 98.